Peptidyss

Peptidyss is a patented nutraceutical ingredient developed by Abyss Ingredients, derived from natural marine biological resources. It is composed of a synergistic combination of marine peptides and omega-3 fatty acids designed to support cognitive health and psychological well-being. Developed through the VIPP research project and the SeaMind collaborative research program (in partnership with NutriNeuro), Peptidyss is intended for use as an oral dietary supplement ingredient. It has demonstrated efficacy in preclinical and clinical studies for limiting neuroinflammation, reducing anxiety, and improving the body's physiological response to stress. The ingredient is typically formulated for a daily dosage of approximately 750 mg and is primarily targeted at preventing age-related cognitive decline and supporting overall brain health.

Brand names

Peptidyss

Other names

marine peptides and omega-3